Unichem Laboratories receives USFDA’s ANDA approval for Tizanidine tablets

29 Nov 2012 Evaluate

Unichem Laboratories has received ANDA approval from the United States Food and Administration (USFDA) for Tizanidine Tablets. Tizanidine tablets USP 2mg and 4mg are therapeutically equivalent to ZANAFlEX tablets 2mg and 4mg from Acorda Therapeutics. Tizanidine tablets belong to a group of medicines called skeletal muscle relaxants. Tizanidine tablets is used to help relieve, although not cure, muscle spasms caused by medical conditions such as multiple sclerosis or injuries to the brain or spine.

Further, the product will be commercialized from Unichem’s Goa plant. Further, active pharmaceutical ingredient i.e., Tizanidine Hydrochloride used for this ANDA is also made in-house at Roha plant.

Currently, there are 9 generic approvals, while only 3 companies are dominating the market. The current market size is $70 million growing at 5% in value terms and 10% in volume.

Unichem Lab Share Price

447.15 -6.30 (-1.39%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×